Martin M. Miner, MD, Brown University, Providence, Rhode Island, discusses outcomes of the testosterone trials on clinical practice.

 

 

To view slides from Dr. Miner’s presentation at the 18th Annual Future Directions in Urology Symposium, click here.

Keywords: testosterone, cardiovascular risk

ABOUT THE AUTHOR

Martin M. Miner, MD, is Co-Director of the Men’s Health Center and Chief of Family and Community Medicine for Miriam Hospital in Providence, Rhode Island. He is also Clinical Professor of Family Medicine and Urology at the Warren Alpert Medical School of Brown University in Providence and has been charged with the development of a multidisciplinary Men’s Health Center within the Lifespan/Brown University system. Dr. Miner received his MD from the University of Cincinnati College of Medicine in Ohio. He completed his residency at Brown University and spent time working with the Indian Health Service Corps and the Public Health Service. Dr. Miner presently holds memberships in the American Academy of Family Physicians, the Rhode Island and Massachusetts Academy of Family Physicians, and the American Urological Association, and is a Fellow of the Sexual Medicine Society of North America. He is also a member of the International Society for the Study of Women’s Sexual Health and the former president of the American Society of Men’s Health. He has published extensively in the areas of erectile dysfunction and cardiovascular disease, benign prostatic hyperplasia and lower urinary tract symptoms, and male sexuality and hormonal replacement therapy in men.